The U.S. is number one in per capita use, and there is Europe and Australia. But in a lot of these countries the problem is not manifesting itself as we have seen here, because the supply availability is very different, or at least it hasn't reached our level yet. This is an opportunity for Canada to lead by saying, “If you're going down the road of expanding accessibility to certain drugs, be mindful of these practices”. I think that's an opportunity for Canada.
On November 20th, 2013. See this statement in context.